Puerto Rico’s Business Star Proposition relies on one of the most advanced infrastructures for biotechnology in the planet. It’s no wonder that 12 of the world’s top 20 biotechnology and pharmaceutical companies have presence in Puerto Rico.
Puerto Rico enjoys a long legacy in pharmaceutical and medical device manufacturing. Biologics is also a growing segment of the island's life sciences sector. Amgen, Eli Lilly, Abbott and Becton Dickinson Bioscience alone have invested more than $65.9 million in four plants since 2005. Puerto Rico also boasts the world's largest modular biotechnology plant for producing recombinant human insulin. And last but not least, the island has emerged as an important center for agricultural biotechnology. Bio-Agriculture
Puerto Rico's workforce has vast knowledge in GMP, FDA and other global regulations, while the island's university system turns out a steady stream of new talent:
This is the largest component of the biotechnology industry. Key product areas include biological drugs, vaccines, and in-vitro diagnostics. Principal targets for research and development are treatments for cancers, infectious diseases, autoimmune conditions, HIV/AIDS, and other diseases for which no effective treatments exist.
Key products in this subsector include a large number of industrial applications that cut across other industry sectors. Primary product categories are nanotechnology, enzymes, and biofuels.
Key products include biotech crops such as corn, soybeans, cotton and canola, as well as crop seeds and related products. Bio-Agriculture
Contact Us to learn more about opportunities in the Biotechnology sector.
Get to know our incentive packages for the manufacturing industry.